Zai Lab Announces First Patients Treated in Separate Phase 1b and Registrational Bridging Studies

NEXT STORY
Inato Raises $14 Million in Series A Funding from Obvious Ventures, Cathay Innovation, Serena and Fly Ventures
PREV STORY
Global $10+ Billion Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight, 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

IVD Infectious Diseases: Worldwide Market Forecast Report to 2026 – Introduction of Technologies such as qPCR & ELISA has Enhanced Usage Rates of IVD Products for Infectious Disease Testing

author_avatar
NASDAQ Market News

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

author_avatar
NASDAQ Market News

Basilea announces clinical study agreement with Adult Brain Tumor Consortium to explore BAL101553 in newly diagnosed glioblastoma

The Adult Brain Tumor Consortium (ABTC) is designed to develop more effective treatments for ...

author_avatar
NASDAQ Market News